Skip to content Skip to footer
Menu Close
Close
Refer A Friend
Get in Touch

Atopic Dermatitis Clinical Trials for Adolescents & Adults

See if You or Someone You Know Qualifies Today!
Dermatology

Atopic Dermatitis Disrupting Your Life?

Clinical Trials for Adolescents and Adults May Help You Take Control

Atopic dermatitis (AD), the most common form of eczema, is a chronic, inflammatory skin condition that causes the skin to become extremely itchy, red, dry, and cracked. It can affect people of all ages, though it is more common in children. The condition may come and go over time, with periodic flare-ups triggered by environmental allergens, stress, irritants, or infections. AD is often linked to other allergic conditions, such as asthma and hay fever, and is thought to result from a combination of genetic, immune system, and environmental factors.

According to the national eczema association, around 9.6 million children and adolescents in the United States have atopic dermatitis, with about one-third experiencing moderate to severe cases. In teens, the condition may affect not only the skin but also one’s emotional well-being and self-esteem. The weakened skin barrier increases sensitivity to allergens and irritants, leading to flare-ups, discomfort, and social anxiety during critical developmental years.

If you or someone you know has atopic dermatitis, revival research institute is conducting Atopic Dermatitis Clinical Trials for Adolescents & Adults, exploring potential new treatment options.

Is this Clinical Trial a Fit for You?

To qualify for the Atopic Dermatitis Clinical Trials currently enrolling, participants must meet the following criteria:

  • Be 12 years of age or older at the time of consent
  • Have moderate to severe atopic dermatitis affecting the hands and/or feet
  • Have experienced chronic symptoms for at least one year prior to screening

*Additional criteria may apply.

Participation in Atopic Dermatitis Clinical Trials provides a chance to receive expert care, free study-related care and medication, and regular health monitoring by experienced medical professionals.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
This is our Privacy Policy.

About the Atopic Dermatitis Clinical Trials for Adolescents & Adults

Living with atopic dermatitis can take a toll on one’s day-to-day life. The relentless itching, skin irritation, and discomfort can disrupt sleep, impact self-esteem, and make everyday routines more difficult.

Revival Research Institute is conducting clinical trials for individuals with moderate to severe atopic dermatitis. Clinical trials are designed to explore the safety and efficacy of investigational treatments that may help reduce such as inflammation, itching, and flare-ups.

Atopic Dermatitis Clinical Trials will be conducted in several locations across the United States. To ensure study eligibility, participants must comply with all study procedures. To qualify, participants must meet specific eligibility criteria and agree to follow all study procedures. After the screening process, eligible individuals will be randomly assigned to receive either the investigational treatment or a placebo.

*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate. Participants may receive compensation for time and travel.

*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. There may be a brief discussion about your health and medical history.

Get Started
What to Expect?

If you are living with atopic dermatitis, you may qualify for a paid clinical trial exploring new treatment options for atopic dermatitis. After completing the interest form above, someone from our research team will contact you for a brief pre-screening to see if you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which explains all study procedures, potential benefits, and risks.

Following your consent, you will be invited to a screening visit to our clinical research site. During this initial visit, we will ask questions about your medical history, perform physical exams, and run lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the clinical trial.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. Feel free to ask any questions before deciding to participate. Your participation helps advance future treatments for atopic dermatitis.

Get Started
Age Icon
Age

12 years or older

Condition Icon
Condition

Atopic Dermatitis (Adolescents & Adults)

Location Icon
Location

Georgia & Michigan

Struggling with Atopic Dermatitis in Adolescents & Adults?

Discover a New Path to Wellness Through Clinical Trials

Atopic dermatitis (AD) is a chronic, relapsing skin condition characterized by intense itching, redness, dryness, and inflammation. It commonly affects areas such as the face, neck, hands, inner elbows, and knees—though it can occur anywhere on the body. In moderate to severe cases, the itch-scratch cycle can lead to skin thickening, open sores, and infections.

For many, atopic dermatitis significantly impacts quality of life, leading to sleep disturbances, emotional stress, and social withdrawal.

Skin barrier dysfunction and immune dysregulation are key contributors to the condition, with flares often triggered by allergens, climate changes, and irritants. Many patients experience limited relief or become resistant to standard treatments, underscoring the urgent need for newer, more effective therapeutic options.

Atopic Dermatitis May Be Triggered By

  • Genetic predisposition (family history of eczema, allergies, or asthma)
  • Environmental allergens (pollen, dust mites, pet dander)
  • Irritants (soaps, detergents, fragrances)
  • Stress and emotional triggers
  • Dry weather or extreme temperature changes

Common Symptoms of Atopic Dermatitis

  • Persistent itching, especially at night
  • Red, inflamed, or dry patches of skin
  • Cracked, scaly, or leathery skin
  • Lesions that ooze or develop scabs during flare-ups

Frequently Asked Questions

Helpful Info for Patients & Families

Living with Atopic Dermatitis can be challenging, and it’s natural to have questions. We’ve answered some of the most asked questions about the condition—its symptoms, triggers, and everyday management—to help you feel more informed and supported. Looking for more guidance? Reach out to our amazing team: (248) 721-9539

Atopic dermatitis in adults and adolescents is a chronic skin condition marked by dry, itchy, and inflamed skin. It can interfere with sleep, school, work, and social activities due to the discomfort and appearance of skin lesions. The severity and triggers can vary by age group and may often require long-term management.

Atopic dermatitis is caused by a combination of genetic, environmental, and immune system factors. Skin barrier dysfunction and an overactive immune response contribute to inflammation. Common triggers include allergens, irritants, stress, climate changes, and hormonal fluctuations during adolescence.

Participants are usually diagnosed based on criteria such as Eczema Area and Severity Index (EASI), Investigator’s Global Assessment (IGA), and patient-reported itch severity using a Numerical Rating Scale (NRS). There may be other assessment and diagnostic tools used by the research team to see if you fit the criteria of the study.

Yes, adolescents may respond differently to treatments due to hormonal changes, body weight, and developing immune systems. That’s why clinical trials like this one evaluate safety and efficacy in both age groups to ensure appropriate treatment options are available for all.

Clinical trials provide access to new investigational treatments not yet available to the public. Participants receive close medical supervision, study-related care at no cost, and contribute to the advancement of better therapies for people with atopic dermatitis.